About
Steven Paul is our Interim President of R&D, a member of the Board of Directors and a Venture Partner at Third Rock Ventures. Steven Paul has had a distinguished career in neuroscience with an extensive track record in CNS drug discovery and development. He joined Third Rock in 2010, where he serves as a senior advisor to the firm and participates in the ideation and development of new companies. Steven Paul also currently leads the Appel Alzheimer's Disease Research Institute at Weill Cornell Medical College. Preceding his appointment at Weill Cornell, Steven Paul spent 17 years at Eli Lilly, during which time he held several key leadership roles, including President of the Lilly Research Laboratories, and Vice President of Discovery Research and Neuroscience Research. As President of the Lilly Research Laboratories, he was responsible for the company's overall R&D strategy, expanding its efforts in oncology and biotechnology and resulting in a pipeline of approximately 70 new molecu
Position in the VCSift Database
- • 2,540 investors hold the Co-Founder role in VCSift. Steven Paul is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Steven
Search Investors